• For a global biotechnology company, acted as a strategic advisor to manage all the partner contracts, developed CMC clinical accelerator, and develop onboarding tools that facilitated the expansion of the team from 15 to 50 members; the success of the project resulted in client extending contract for an additional 9-months.
• For a global biotechnology company, managed phases 1 and 2 of an FDA fast-track designated Respiratory Syncytial Virus vaccine program; developed a real-time clinical data dashboard by designing the data process frameworks and logic of the case dashboard outputs which was leveraged for other priority programs across the organization.
• In the pre-launch of biopharma tech startup, assembled a robust advisory board of industry veterans and AI experts, focusing on product ideation to enhance interconnectedness and interoperability in biopharmaceutical organizations.

Strategy
• For a global pharmaceutical company, part of the $70B acquisition, as the core R&D team to conduct vendor assessments, identified areas of operational inefficiencies, designed a new clinical vendors partnership framework, and developed a tracking tool measuring 50+ metrics in real-time.
• For a specialty pharmaceutical company, developed an early market access strategy for an orphan drug in non-cystic fibrosis bronchiectasis and geographic expansion roadmap for 6 countries across 3 continents.
• For a leading pharmaceutical company, devised US market access strategy of a gastrointestinal drug by mapping patients across 125 hospital systems and engaging with 20+ Key Opinion Leaders Practice & Business Development
• Let the recruitment efforts to expand the Pharma & Life Sciences team by 400% in 3 years and mentored the incoming consultants towards professional development.
• Developed an automated drug regulatory and market access platform as a new service offering with

• Converted a part-time internship into a full-time opportunity to join as number 3 employee and work closely with the CEO to delivered 12 global market access assessments which contributed to $1.5M in sales during the first year of its incorporation.
• Handled expansion and contracts of 75+ national, regional, and local level payer advisors spanning across 15+ countries.